Clinical Trial Update: A Study to Assess the Effects of CT-868 Treatment on Glucose Homeostasis in Participants with Type 1 Diabetes [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 study evaluating CT-868 for effects on glucose homeostasis in participants with Type 1 Diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• CT-868

Snippet

Sponsor: Carmot Therapeutics, Inc. | Conditions: Type 1 Diabetes | Phase 1 | Status: COMPLETED